Pharmaceutical Glass Container Industry Analysis in Europe

Europe Pharmaceutical Glass Container Industry Outlook from (2023 to 2033)

Sales of pharmaceutical glass containers in Europe are estimated to be valued at US$ 3,582.89 million in 2023 and US$ 5,656.8 million by 2033. Over the forecast period from 2023 to 2033, Europe is poised to exhibit a CAGR of 4.7%.

In 2023, the total pharmaceutical glass container business revenue in Europe reached US$ 3,437.0 million and is anticipated to exhibit a y-o-y growth of 4.21% in 2023. Hence, a positive growth trajectory has been predicted for Europe through 2033.

Top Segments and their Statistics-

• The bottles segment is set to remain the leading container category across Europe, holding a value share of over 65% by 2033. It is anticipated to thrive at a CAGR of 4.4% during the assessment period.
• Type 1 glass segment is set to expand at a CAGR of 5.0% from 2023 to 2033. It is estimated to reach US$ 1,623.0 million in 2023.
• Type 3 glass segment is set to hold about 1/4th of the revenue by the end of the forecast period.
• Screw cap segment is expected to reach a valuation of US$ 2,224.9 million in 2023.
• Crimp seal is gaining traction and is projected to expand at a CAGR of 5.5% during the evaluation period.
• By forming process, the blowing segment is anticipated to total a valuation of US$ 3,693.9 million by 2033. It will likely hold a value share of 65.3% by the end of 2033.

Attributes	Key Insights
Europe Pharmaceutical Glass Container Revenue in 2022	US$ 3,437.0 million
Estimated Europe Pharmaceutical Glass Container Revenue in 2023	US$ 3,582.8 million
Projected Europe Pharmaceutical Glass Container Revenue in 2033	US$ 5,656.8 million
Value-based CAGR (2023 to .2033)	4.7%

Key Highlights of the Report

Revenue to Expand About 1.6X in Europe through 2033

Europe pharmaceutical glass container business revenue is projected to expand around 1.6X through 2033, amid a 0.5% increase in anticipated CAGR compared to the historical one. This is attributable to the growing prevalence of chronic diseases, increasing medical spending, and rising new drug development activities.

Europe is witnessing a rapid expansion of the pharmaceutical sector on the back of rising cases of chronic diseases and an increasing geriatric population. This is expected to uplift the demand for pharmaceutical glass containers as they are considered safe and reliable pharmaceutical packaging options.

Other Trends in the Pharmaceutical Glass Container Business in Europe include:

• Rising sales of pharmaceutical glass tubing
• Increasing share of pharmaceutical e-commerce
• Growing demand for biologics and personalized medicine
• Innovation in glass containers for pharmaceutical products

Bottles, Vials, and Ampoules Segments to Collectively Hold Over 91% Share

As per the new Europe pharmaceutical glass container industry analysis, bottles and vials & ampoules segments are anticipated to hold over 91% value share in 2033 collectively. This is due to the rising usage of bottles, vials, and ampoules for packaging a wide variety of pharmaceutical formulations.

Glass bottles have become highly suitable packaging for storing, protecting, and transporting medications. These are set to be widely used for oral drugs, syrups, and other liquid formulations.

Glass vials are also increasingly used to package injectable drugs, while glass ampoules are employed for liquid medications. Hence, the growing usage of glass-based bottles, vials, and ampoules for packaging drugs and medicines due to their several benefits will boost the target segments.

Germany to Lead in Terms of Pharmaceutical Glass Container Consumption

Germany is set to lead Europe in terms of pharmaceutical glass container consumption. As per the latest report, Germany will likely hold a dominant value share of around 23.9% by 2033. This is due to factors including:

• Rising Demand for Pharmaceutical Products: Germany is home to one of the leading pharmaceutical sectors. The country is witnessing a high demand for pharmaceutical products due to the rising cases of chronic diseases and the aging population. This is expected to boost sales of pharmaceutical glass containers.
• Implementation of Stringent Regulations: Germany has strict regulations regarding the packaging of pharmaceutical products. This is anticipated to encourage the adoption of glass containers as they are safe and reliable for storing and protecting pharmaceutical formulations.
• Rise of the Biopharmaceutical Sector: The biopharmaceutical sector thrives rapidly across Europe, creating a surging demand for pharmaceutical glass containers. This is because biopharmaceutical products are very susceptible and require special packaging, including glass containers, to protect them from degradation.

Transition toward Sustainable Packaging Creating Prospects for Manufacturers

There is a growing focus on sustainability in the pharmaceutical sector across Europe amid rising levels of plastic pollution in the environment. This creates a conducive environment for the growth of the pharmaceutical glass container business, as these are seen as more sustainable packaging options.

Glass is fully recyclable and can be easily recycled repeatedly without losing quality. This makes it an eco-friendlier option than other packaging materials. Amid tightening government regulations on plastic usage, businesses that provide sustainable pharmaceutical packaging, such as glass containers, are set to succeed in the assessment period.

Europe Pharmaceutical Glass Container Space Overview

Pharmaceutical glass containers are becoming an essential part of the pharmaceutical packaging system. This is because they ensure the safety, efficacy, and stability of pharmaceutical products. They are set to be designed to both uphold high medical standards and ergonomically protect the integrity of a product.

The ability of pharmaceutical glass containers to safely and effectively protect and deliver a wide variety of pharmaceutical products is set to boost their demand across Europe. These glass containers are giving tough competition to pharmaceutical containers, including plastic vials, due to their sustainable nature and other advantages.

The availability of pharmaceutical glass containers in a variety of shapes and sizes is another key factor fueling their adoption in the pharmaceutical sector. These containers come in different forms, including bottles, ampoules, vials, and jars.

The growing popularity of biopharmaceutical and specialty drugs is anticipated to drive sales of pharmaceutical glass containers. This is because these drugs often need specialized packaging solutions, such as glass containers, which can help maintain their integrity.

Top companies are also innovating to develop novel pharmaceutical glass containers, such as coated ones. Several companies are focusing on introducing amber glass containers to protect light-sensitive pharmaceutical products. This will likely boost the total revenue in Europe.

Historical Vs. Forecast Europe Pharmaceutical Glass Container Industry Outlook

Sales of pharmaceutical glass containers in Europe grew at a CAGR of 4.2% during the historical period. Total sales value in the region increased from US$ 2,916.2 million in 2018 to US$ 3,437 million in 2022.

Over the forecast period, pharmaceutical glass container sales in Europe will likely soar at 4.7% CAGR. It is expected to attain a valuation of US$ 5,656.8 million by 2033.

Historical CAGR (2018 to 2022)	4.2%
Forecast CAGR (2023 to 2033)	4.7%

The rise of biopharmaceuticals and biologics is creating a high demand for specialized glass containers that can accommodate these complex and sensitive formulations. These containers need to maintain the stability and potency of such advanced therapies.

Rising healthcare demands would drive the need for pharmaceutical glass packaging. The expanding pharmaceutical sector relies on these containers to maintain drug effectiveness and quality.

The growing demand for pharmaceutical products is expected to bolster sales of pharmaceutical glass containers. This is because several pharmaceutical formulations require high-quality packaging and glass-based containers offer excellent protective properties, such as chemically inert and rigid.

There is a growing emphasis on sustainable packaging solutions in the pharmaceutical sector. Manufacturers are focusing on developing eco-friendly containers, such as glass-based ones, that reduce waste generation and have a minimal environmental impact. The growing usage of these sustainable packaging solutions is set to boost revenue across Europe.

Semi-Annual Update

The table presents the expected CAGR for the Europe pharmaceutical glass container business over several semi-annual periods from 2022 to 2033. In the first half (H1) of the decade from 2022 to 2032, the business is expected to surge at a CAGR of 4.4%, followed by a slightly lower growth rate of 4.2% in the second half (H2) of the same decade.

Moving into the subsequent period, from H1 2023 to H2 2033, the CAGR is projected to increase slightly to 5.0% in the first half and remain moderate at 4.7% in the second half. These values offer insights into the anticipated growth trends for the Europe pharmaceutical glass container business, aiding stakeholders and investors in making informed decisions regarding investments & strategies.

Particular	Value-based CAGR
H1 (2022 to 2032)	4.4%
H2 (2022 to 2032)	4.2%
H1 (2023 to 2033)	5.0%
H2 (2023 to 2033)	4.7%

Key Dynamics

High Adoption of Glass Vials to Boost Sales across Europe

To offer and maintain the requisite quality of sensitive medicines and drugs, pharmaceutical producers must act. Drugs and medicines lose a handful of their potency when they come into contact with drug storage containers made of metals such as aluminum, which lend flavor to the drugs. This puts pharmaceutical glass containers, including glass vials, into the spotlight.

The drug stored inside the glass vials makes them non-reactive. These glass vials are also easy to clean and dust-resistant. The popularity of glass vials is increasing due to their several advantages, such as longer shelf lives and contamination-free storage.

Glass vials are becoming increasingly popular among a variety of end users, including hospitals, medical facilities, and pharmaceutical companies. This is expected to boost sales of pharmaceutical glass vials and revenue in Europe.

As glass vials are readily recyclable, they are seen as an environmentally benign material, which ultimately increases their popularity. The Europe pharmaceutical glass container business will expand rapidly due to end customers' shifting preference from conventional containers and vials to glass vials.

Increasing Drug Development and Manufacturing Activities to Elevate Demand

The pharmaceutical glass container business in Europe is being propelled by the burgeoning pharmaceutical production and development sector. A greater need for high-quality and customized glass containers for packaging sensitive pharmaceuticals and biologics has arisen due to increased pharmaceutical research and rising demand for medications and treatments.

Pharmaceutical firms are investing significantly in creating novel medication formulations, such as biologics, sterile injectables, and other cutting-edge treatments. More companies are using specialized pharmaceutical glass containers as a result of the requirement to guarantee medicine stability, avoid contamination, and adhere to regulatory norms.

Stringent Regulatory Guidelines in Europe Bolstering Sales

Adherence to strict regulatory criteria is essential in the Europe pharmaceutical sector to maintain product quality and assure patient safety. For this purpose, pharmaceutical companies are employing safe and sterile packaging solutions such as glass containers.

The requirement for packing materials that reduce the danger of contamination and chemical interactions is further highlighted by the strict regulatory framework imposed by the European Union (EU). These include good manufacturing practices and quality management systems. Driven by this, pharmaceutical glass container consumption is set to rise rapidly in Europe.

Pharmaceutical glass containers are becoming a popular choice in Europe. This is due to their superior chemical stability, low extractable and leachable profiles, and compatibility with a variety of medication formulations.

Pharmaceutical glass containers would show a dedication to the strict requirements of the region as pharmaceutical businesses negotiate the complicated terrain of legislation. These containers are crucial in protecting drug goods from outside influences, helping to establish Europe as a global leader in manufacturing safe and effective medications.

Overview of Restrictive Factors for Europe Pharmaceutical Glass Container Space

• Pharmaceutical glass containers are costly compared to plastic ones. This is limiting their adoption in certain countries across Europe.
• Pharmaceutical glass containers are also heavier and more fragile. This makes their handling and transportation quite challenging.

Comparative View of Adjacent Businesses

The pharmaceutical glass container business in Europe will likely be impacted by the tangential or peer businesses in the packaging division. These include businesses such as glass containers and pharmaceutical vials. Knowledge of these related fields can help companies get an in-depth analysis of the overall scenario and frame their strategies accordingly.

Europe Pharmaceutical Glass Container Industry Analysis:

Attributes	Europe Pharmaceutical Glass Container Industry Analysis
CAGR (2023 to 2033)	4.7%
Estimated Value (2023)	US$ 3,582.8 million
Growth Factor	Increasing drug development and manufacturing activities will likely uplift the demand for pharmaceutical glass containers in Europe.
Key Trend	Integration of novel technologies such as sensors, RFID tags, or QR codes in smart glass containers to enable real-time monitoring of product conditions, enhance supply chain visibility, and improve patient safety is a crucial trend.

Global Glass Container Industry Analysis:

Attributes	Glass Container Sales Outlook
CAGR (2023 to 2033)	5.2%
Estimated Value (2023)	US$ 61.5 billion
Growth Factor	Growing usage of glass containers across sectors such as pharmaceuticals, cosmetics, and food & beverage is expected to boost sales.
Key Trend	Rising demand for home décor and eye-catching surroundings is encouraging the adoption of glass containers.

Pharmaceutical Vial Industry Analysis:

Attributes	Pharmaceutical Vial Demand Outlook
CAGR (2023 to 2033)	7.10%
Estimated Value (2023)	US$ 12,137.2 million
Growth Factor	Rising demand for injectable drugs is expected to bolster sales of pharmaceutical vials.
Key Trend	Advancements in vial technology will likely foster growth.

Country-wise Insights

The table below shows the share of the top countries in Europe pharmaceutical glass container business for the review period from 2023 to 2033. Austria and Belgium are expected to remain dominant by exhibiting CAGRs of 6.0% and 5.7%, respectively. The Netherlands and Italy are projected to follow with CAGRs of 5.6% and 5.0%, respectively.

Country	Value-based CAGR
Germany	4.1%
Austria	6.0%
Belgium	5.7%
Netherland	5.6%
United Kingdom	3.6%
Italy	5.0%
Rest of Europe	6.3%

Booming Pharmaceutical Sector Driving Demand in Germany

As per the latest Europe pharmaceutical glass container industry analysis, Germany is anticipated to hold around 25% of the share in Europe by 2023. Over the forecast period, pharmaceutical glass container demand in Germany is predicted to rise at 4.1% CAGR.

Several factors are expected to drive the demand for pharmaceutical glass containers in Germany through 2033. These include the expanding pharmaceutical sector, rising drug development activities, and the presence of leading pharmaceutical giants.

In Europe, Germany has a strong pharmaceutical and biotechnology sector, with several indigenous enterprises conducting pharmaceutical product development. This is creating a high demand for pharmaceutical packaging, such as pharmaceutical glass containers.

Germany is also the leader in drug development, offering attractive business solutions for foreign biotech companies, including research and development collaborations, establishing headquarters, or entering strategic partnerships. This is expected to boost the target business.

Implementation of Stringent Regulations Bolstering Sales in Italy

According to the report, sales of pharmaceutical glass containers in Italy are expected to soar at a CAGR of 5.0% during the assessment period. Total revenue in the country is set to reach around US$ 516.7 million by 2033.

Sales in Italy are expected to be driven by factors such as the growing pharmaceutical sector, technological advancements, and the implementation of serialization and aggregation regulations.

Pharmaceutical glass containers play a crucial role in the serialization process. They are set to be used as primary packaging for drugs. Hence, serialization is directly related to pharmaceutical glass containers as they are an integral part of the packaging design that carries unique identifiers.

Rising Demand for Pharmaceutical Drugs Boosting Revenue in the United Kingdom

The United Kingdom is set to remain a highly lucrative nation for pharmaceutical glass container manufacturers across Europe. It is expected to attain a valuation of US$ 929.5 million by 2033, exhibiting a CAGR of 3.6%.

Rising prevalence of chronic diseases and increasing demand for pharmaceuticals are key factors expected to drive sales growth in the United Kingdom. Similarly, the rising popularity of injectable drugs contributes to the demand for pharmaceutical containers in the country.

Pharmaceutical demand in the United Kingdom is expected to rise significantly during the forecast period, owing to the growing geriatric population and rising incidence of chronic diseases. This will likely boost pharmaceutical glass container sales in the country.

Another key factor expected to fuel demand for pharmaceutical glass containers in the United Kingdom is the rising preference for sustainable packaging. This is because both pharmaceutical companies and consumers are shifting their preference from plastic pharmaceutical packaging to glass.

Surging Popularity of Injectables Creating Growth Prospects in Austria

Austria is forecast to become an attractive destination for pharmaceutical glass container companies. This is due to the rising popularity of injectables and biologics, increasing healthcare spending, and expansion of the generics sector.

From 2023 to 2033, pharmaceutical glass container sales in Austria are anticipated to surge at 6.0% CAGR. Total revenue in the country is set to reach around US$ 177.1 million by 2033.

Demand for injectable drugs is rising significantly across Austria, and this is expected to fuel sales of pharmaceutical glass containers through 2033. This is because injectables are often packaged in syringes, vials, and ampoules.

Growing Focus on Reducing Plastic Waste to Uplift Demand in Belgium

Belgium is projected to witness steady growth during the forecast period. This is attributable to the rising focus on using sustainable pharmaceutical packaging and the growing popularity of biologics. The rising demand for glass packaging for biopharmaceutical products in Belgium is also set to aid growth.

Demand for pharmaceutical glass containers in Belgium will likely increase at 5.7% CAGR throughout the forecast period. By 2033, the total pharmaceutical glass container revenue in the country is expected to reach US$ 230.7 million.

Glass is becoming an ideal packaging material for several pharmaceutical products owing to its inert nature. Leading pharmaceutical giants in Belgium are shifting their preference toward using glass containers to package a wide variety of pharmaceutical drugs. This will elevate demand in the country.

Surging demand for biologics such as vaccines and monoclonal antibodies is another prominent factor expected to boost sales in Belgium. This is because biologics are primarily packaged glass vials or syringes.

Category-wise Insights

The below section predicts the vials and ampoules segment to witness a higher CAGR compared to other container types. It will likely thrive at 5.3% CAGR during the assessment period.

Based on closure, the screw cap segment is set to generate significant revenue across Europe. It is predicted to progress at a CAGR of 4.3% between 2023 and 2033.

Rising Demand for Parenteral Drugs Triggering Sales of Vials and Ampoules

Container Type	Value CAGR
Vials and Ampoules	5.3%
Bottles	4.4%
Syringes	4.5%

As per the Europe pharmaceutical glass container industry analysis, the bottle segment is expected to constitute more than 65% share by the end of 2033. This is due to the high adoption of glass bottles for packing a wide variety of pharmaceutical formulations, including oral liquids, tablets, and capsules.

Among the sub-categorization, the oral liquid category holds over 50% of the share as it includes a wide variety of drug products, such as syrups, suspensions, and solutions, that are intended for oral administration. They are expected to be used for patients who have difficulty swallowing or for medications that require a more rapid onset of action.

The emerging statistics, however, estimate the vials and ampoules segment to witness a higher CAGR of 5.3% over the forecast period. It will likely hold around 1/4th of the share by 2033. This is attributable to the increasing adoption of sterile vials and other sterile primary containers and the growing demand for parenteral drugs, such as insulin and corticosteroids.

Sterile vials are set to be designed to maintain sterility throughout the entire supply chain. This would help prevent contamination and ensure that the drug product is safe for use in the pharmaceutical sector.

Healthcare professionals emphasize the importance of ensuring that patients take the right dosage of medication. This is expected to increase the popularity of pharmaceutical vials.

Constant innovations in the pharmaceutical sector, such as blow fill seal (BFS) vials and anti-counterfeit measures, are also driving the adoption of pharmaceutical vials. To gain maximum profits, key pharmaceutical glass container manufacturers are projected to improve their vials and ampoules portfolios.

Excellent Compatibility and Security Fueling Adoption of Screw Caps

Product Type	Value CAGR
Screw Cap	4.3%
Flip Off Seal	5.0%
Crimp Seal	5.5%

Based on closure, the screw cap segment is projected to hold about 60% of value share by 2033. The target segment is poised to exhibit a CAGR of 4.3% during the forecast period. This is due to the rising adoption of pharmaceutical screw caps to package a variety of products.

Screw caps are set to be widely used in the pharmaceutical sector to protect medicinal supplies. They are anticipated to be designed to provide a secure and tamper-evident seal, thereby protecting the contents from contamination.

Screw caps would act as a child-proof mechanism and promote intuitive and precise dosage dispensing. Their ability to create an airtight barrier that shields the contents from oxygen and extends product shelf life would expand use.

The growing usage of screw caps, such as standard screw caps and child-resistant screw caps, will likely boost the target segment through 2033. Screw caps have a wider range of chemical compatibility and are the most temperature-tolerant plastic closures, which makes them ideal pharmaceutical closure types.

Competitive Landscape

Leading pharmaceutical glass container manufacturers are focusing on developing innovations and advancements to boost their sales. They are also implementing strategies such as mergers, acquisitions, partnerships, facility expansions, and distribution agreements.

Recent Developments:

• In September 2023, Piramal Enterprise Ltd. announced an investment of around US$ 63 million in Ivy Health and Life Sciences Private Limited to promote the healthcare sector.
• In June 2023, SGD Pharma and Corning Incorporated announced a joint venture to establish a new glass tubing facility in India.
• In March 2022, Sisecam Group announced the expansion of its production footprint in Europe to enhance its glass packaging business.
• In August 2020, Nipro Corp. announced the acquisition of MTN Neubrandenburg GmbH to strengthen the supply system of dialysate in Europe and to increase sales of other products for dialysis treatment.

Scope of the Report

Attribute	Details
Estimated Value (2023)	US$ 3,582.8 million
Projected Value (2033)	US$ 5,656.8 million
Anticipated Growth Rate (2023 to 2033)	4.7% CAGR
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	Value (US$ million)
Segments Covered	Container Type of Glass Closure Forming Process Country
Key Companies Profiled	Corning Inc. Gerresheimer AG Sisecam Group Nipro Corp. West Pharmaceutical Services Ardagh Group Schott AG Piramal Enterprise Ltd. Beaston Clark Ltd. Nekem Packaging SGD Pharma Stolzle Glass Group Origin Pharma Packaging
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Europe Pharmaceutical Glass Container Industry Outlook by Category

By Container:

• Vials and Ampoules
• Parenteral
• Non Parenteral
• Bottles
• Oral Liquids
• Tablets
• Capsules
• Topical
• Syringes

By Glass:

• Type 1
• Type 2
• Type 3
• Type 4

By Closure:

• Screw Cap
• Flip Off Seal
• Crimp Seal

By Forming Process:

• Blowing
• Drawing
• Pressing
• Casting

By Country:

• Germany
• Italy
• France
• United Kingdom
• Spain
• Belgium
• Netherland
• Denmark
• Sweden
• Poland
• Austria
• Rest of Europe

Frequently Asked Questions

How big is the pharmaceutical glass container business in Europe?

Total revenue in Europe is anticipated to reach US$ 3,582.8 million in 2023.

What is the sales forecast for pharmaceutical glass containers in Europe?

Sales in Europe are set to total US$ 5,656 million by 2033.

At what rate did sales grow in Europe over the last four years?

Sales grew at around 4.2% CAGR over the last four years.

What is the demand outlook for pharmaceutical glass containers in Europe?

Demand in Europe is expected to rise at 4.7% through 2033.

What type of glass container is used for pharmaceutical purposes?

Type 1 glass containers are mainly used for pharmaceutical purposes.